Application 761028
- Type
- BLA
- Sponsor
- AMGEN INC
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761028 | Mvasi | bevacizumab-awwb | 351(k) Biosimilar | Rx | 2026-07-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MVASI | BEVACIZUMAB-AWWB | INJECTABLE; INJECTION | 100MG/4ML (25MG/ML) | No | No |
| 002 | MVASI | BEVACIZUMAB-AWWB | INJECTABLE; INJECTION | 400MG/16ML (25MG/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MVASI | BEVACIZUMAB-AWWB | Amgen, Inc | 0a562b4e-67ce-4bab-852c-d9ee71e55fb8 | 2026-06-23 | Warnings, Adverse reactions | BLA761028 55513-207 55513-206 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 55513-206 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-206 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-206 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-206 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-206 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-206 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-206 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-207 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-207 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-207 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-207 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-207 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-207 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |
| 55513-207 | MVASI | bevacizumab-awwb | Amgen Inc | BLA | Current |